BOT 0.00% 7.9¢ botanix pharmaceuticals ltd

This part of the study is very interesting, IMO (under the...

  1. 1,400 Posts.
    lightbulb Created with Sketch. 560
    This part of the study is very interesting, IMO (under the heading "CBD effects and mechanisms of immune suppression in innate cells") :

    "IL-6 is a proinflammatory cytokine produced by many cell types, predominantly innate cells. Many studies have shown that circulating IL-6 is readily inhibited by CBD in inflammatory models, including diabetes,124 asthma,127 pancreatitis,128 and hepatitis.86 CBD treatment in vivo resulted in lower IL-6 production in peritoneal macrophages stimulated ex vivo with LPS,124 in the pancreas in acute pancreatitis,128and in bronchoalveolar lavage fluid in LPS-induced pulmonary inflammation.125

    (my emphasys)

    LPS, lipopolysaccharide, are large molecules found in the outer membrane of Gram-negative bacteria, and on this forum it was posted that BOT has lodged patent applications for the use of CBD to treat those bugs.
    Furthermore, the IL-6 receptor is the target of Tocilizumab (Actemra), Roche’s anti-inflammatory drug that's got the seal of approval from the Chinese National Health Commission’s new treatment guidelines for COVID-19 released earlier this week and now made available for free in Italy too following successful trials there:

    ...just joining the dots, not saying that BOT's CBD compounds can cure the virus, just a puzzling 'coincidence'....(?)

    Last edited by aburbe: 13/03/20
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Mkt cap ! $76.87M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $110.7K 1.392M

Buyers (Bids)

No. Vol. Price($)
6 616289 7.8¢

Sellers (Offers)

Price($) Vol. No.
7.9¢ 26447 1
View Market Depth
Last trade - 15.59pm 11/05/2021 (20 minute delay) ?
0.000 ( 1.76 %)
Open High Low Volume
7.9¢ 8.0¢ 7.8¢ 655660
Last updated 15.59pm 11/05/2021 (live) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.